Jurema Schmidt

616 total citations
28 papers, 499 citations indexed

About

Jurema Schmidt is a scholar working on Oncology, Molecular Biology and Biochemistry. According to data from OpenAlex, Jurema Schmidt has authored 28 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Biochemistry. Recurrent topics in Jurema Schmidt's work include Drug Transport and Resistance Mechanisms (8 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Jurema Schmidt is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Jurema Schmidt collaborates with scholars based in Germany, Switzerland and Italy. Jurema Schmidt's co-authors include Daniel Merk, Astrid Kaiser, Ewgenij Proschak, Manfred Schubert‐Zsilavecz, Dieter Steinhilber, Jan Heering, T Gramatté, Lilia Weizel, Mario Wurglics and Pascal Heitel and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

Jurema Schmidt

27 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jurema Schmidt Germany 15 222 105 85 83 72 28 499
Melvin Reichman United States 16 350 1.6× 108 1.0× 188 2.2× 112 1.3× 84 1.2× 28 852
Janice C. Parker United States 15 342 1.5× 92 0.9× 99 1.2× 77 0.9× 35 0.5× 23 689
Ralph Mosley United States 12 698 3.1× 54 0.5× 96 1.1× 172 2.1× 83 1.2× 15 1.2k
Gamini Chandrasena United States 17 260 1.2× 64 0.6× 128 1.5× 133 1.6× 20 0.3× 32 577
Erik T. Bodor United States 10 344 1.5× 50 0.5× 101 1.2× 52 0.6× 34 0.5× 16 688
Kazunobu Aoyama Japan 14 199 0.9× 83 0.8× 73 0.9× 42 0.5× 41 0.6× 19 409
Beverley Hammond United Kingdom 9 145 0.7× 89 0.8× 96 1.1× 66 0.8× 23 0.3× 11 418
Cong Xu United States 12 141 0.6× 52 0.5× 82 1.0× 35 0.4× 22 0.3× 16 508
Monica Singer United States 15 187 0.8× 102 1.0× 100 1.2× 212 2.6× 28 0.4× 23 669
J. Prous Spain 12 246 1.1× 93 0.9× 50 0.6× 61 0.7× 31 0.4× 27 665

Countries citing papers authored by Jurema Schmidt

Since Specialization
Citations

This map shows the geographic impact of Jurema Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jurema Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jurema Schmidt more than expected).

Fields of papers citing papers by Jurema Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jurema Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jurema Schmidt. The network helps show where Jurema Schmidt may publish in the future.

Co-authorship network of co-authors of Jurema Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Jurema Schmidt. A scholar is included among the top collaborators of Jurema Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jurema Schmidt. Jurema Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Willems, Sabine, et al.. (2021). A New FXR Ligand Chemotype with Agonist/Antagonist Switch. ACS Medicinal Chemistry Letters. 12(2). 267–274. 11 indexed citations
2.
Schmidt, Jurema, et al.. (2021). Differential Therapeutic Effects of FXR Activation, sEH Inhibition, and Dual FXR/sEH Modulation in NASH in Diet-Induced Obese Mice. ACS Pharmacology & Translational Science. 4(2). 966–979. 9 indexed citations
3.
Heitel, Pascal, Jurema Schmidt, Astrid Kaiser, et al.. (2020). A triple farnesoid X receptor and peroxisome proliferator-activated receptor α/δ activator reverses hepatic fibrosis in diet-induced NASH in mice. Communications Chemistry. 3(1). 174–174. 14 indexed citations
4.
Khan, Abdul H., et al.. (2019). A dual farnesoid X receptor/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in mice. Biochemical Pharmacology. 166. 212–221. 24 indexed citations
5.
Schmidt, Jurema, et al.. (2019). Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation. Journal of Medicinal Chemistry. 62(4). 2112–2126. 43 indexed citations
6.
Schmidt, Jurema, M. Hartmann, Astrid Kaiser, et al.. (2019). Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast. ChemMedChem. 15(1). 50–67. 16 indexed citations
7.
Schmidt, Jurema, et al.. (2018). Structural optimization and in vitro profiling of N-phenylbenzamide-based farnesoid X receptor antagonists. Bioorganic & Medicinal Chemistry. 26(14). 4240–4253. 9 indexed citations
8.
Gabler, Matthias, Jan S. Kramer, Jurema Schmidt, et al.. (2018). Allosteric modulation of the farnesoid X receptor by a small molecule. Scientific Reports. 8(1). 6846–6846. 15 indexed citations
9.
Heitel, Pascal, Sabine Willems, Jurema Schmidt, et al.. (2018). Boosting Anti-Inflammatory Potency of Zafirlukast by Designed Polypharmacology. Journal of Medicinal Chemistry. 61(13). 5758–5764. 30 indexed citations
10.
Schmidt, Jurema, Sandra K. Wittmann, Lilia Weizel, et al.. (2017). A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis. Journal of Medicinal Chemistry. 60(18). 7703–7724. 72 indexed citations
11.
Schmidt, Jurema, Matthias Gabler, Pascal Heitel, et al.. (2017). Nonacidic Farnesoid X Receptor Modulators. Journal of Medicinal Chemistry. 60(16). 7199–7205. 70 indexed citations
12.
Schmidt, Jurema, et al.. (2015). NSAIDs Ibuprofen, Indometacin and Diclofenac do not interact with Farnesoid X Receptor. Scientific Reports. 5(1). 14782–14782. 48 indexed citations
13.
Schmidt, Jurema, et al.. (2013). Magnesiation of N‐Methyl‐1, 3‐propylenediaminoboryl Ferrocene. Zeitschrift für anorganische und allgemeine Chemie. 639(7). 1083–1086. 5 indexed citations
14.
Schmidt, Jurema, et al.. (1986). Protective and restitutive effects of antihypoxic drugs on posthypoxic dopamine release inhibition.. PubMed. 45(4). 549–56. 4 indexed citations
15.
Gramatté, T & Jurema Schmidt. (1986). The effect of early postnatal hypoxia on the effectiveness of drugs influencing motor behaviour in adult rats.. PubMed. 45(8). 1069–74. 4 indexed citations
16.
Gramatté, T, et al.. (1986). Effects of nootropic drugs on some behavioural and biochemical changes after early postnatal hypoxia in the rat.. PubMed. 45(8). 1075–82. 2 indexed citations
17.
Bucher, U & Jurema Schmidt. (1985). [Effect of hypobaric hypoxia on motor behavior in rats].. PubMed. 44(7-8). 1163–70. 1 indexed citations
18.
Möller, Reinhard, et al.. (1984). Effects of piracetam on brain development in newborn rats exposed to hypoxia.. PubMed. 43(6). 789–95. 1 indexed citations
19.
Schmidt, Jurema, et al.. (1975). [Activation of the fibrinolytic system by furosemide (author's transl)].. PubMed. 70(26). 1125–7.
20.
Lorenz, W., H. J. Reimann, Jürgen Kusche, et al.. (1975). Proceedings: Effects of (+)-catechin on several enzymes of histamine metabolism and on stress ulcer formation in the female rat.. University of Regensburg Publication Server (University of Regensburg). 287 Suppl. R62–R62. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melvin Reichman Breakdown of academic impact, for papers by Janice C. Parker Breakdown of academic impact, for papers by Ralph Mosley Breakdown of academic impact, for papers by Gamini Chandrasena Breakdown of academic impact, for papers by Erik T. Bodor Breakdown of academic impact, for papers by Kazunobu Aoyama Breakdown of academic impact, for papers by Beverley Hammond Breakdown of academic impact, for papers by Cong Xu Breakdown of academic impact, for papers by Monica Singer Breakdown of academic impact, for papers by J. Prous
Rankless by CCL
2026